Synapses and Alzheimer's Disease

Sheng, M., Sabatini, B. L., Sudhof, T. C.·2012·Cold Spring Harbor Perspectives in Biology

Cited by (441)

Items 401–441 of 441

  1. Faculty Opinions recommendation of Conditional Deletion of Prnp Rescues Behavioral and Synaptic Deficits after Disease Onset in Transgenic Alzheimer's Disease.
    Bernadette Allinquant · 2017 · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature
  2. Blocking the FAM19A5-LRRC4B complex enhances neurite growth and synapse assembly.
    Jae Young Seong · 2023 · Research Square
  3. Brain cancer thrives by hijacking mechanisms to boost synapse strength
    Matthew B. Dalva · 2023 · Nature
  4. Additional file 2 of Elevated ganglioside GM2 activator (GM2A) in human brain tissue reduces neurite integrity and spontaneous neuronal activity
    Yi‐Chen Hsieh, Joseph M. Negri, Amy He, Richard V. Pearse, Lei Liu, Duc Minh Duong, Lori Beth Chibnik, David Alan Bennett, Nicholas T. Seyfried, Tracy L. Young‐Pearse · 2022 · Figshare
  5. Additional file 1 of Elevated ganglioside GM2 activator (GM2A) in human brain tissue reduces neurite integrity and spontaneous neuronal activity
    Yi‐Chen Hsieh, Joseph M. Negri, Amy He, Richard V. Pearse, Lei Liu, Duc Minh Duong, Lori Beth Chibnik, David Alan Bennett, Nicholas T. Seyfried, Tracy L. Young‐Pearse · 2022 · Figshare
  6. Additional file 3 of Elevated ganglioside GM2 activator (GM2A) in human brain tissue reduces neurite integrity and spontaneous neuronal activity
    Yi‐Chen Hsieh, Joseph M. Negri, Amy He, Richard V. Pearse, Lei Liu, Duc Minh Duong, Lori Beth Chibnik, David Alan Bennett, Nicholas T. Seyfried, Tracy L. Young‐Pearse · 2022 · Figshare
  7. Neural Reconnection After Exposure in High Frequency Electromagnetic Fields - In Vivo Study
    Smiljana Paraš, Dragana Šnjegota, Zoran Nj. Ružić, Maja Šibarević, Jovana Grahovac, Milan Paraš, Radoslav Gajanin · 2024 · Research Square
  8. Alzheimer’s disease
    Ivan G. Koychev, John Gallacher · 2020
  9. Early Metabolic Alterations in Cerebrospinal Fluid Fatty Acid Profiles Linked to Cognitive Decline and All-Cause Dementia
    Jacob Apibilla Ayembilla, Yannick N. Wadop, Rebecca Bernal, Biniyam Alemayehu Ayele, Muralidharan Sargurupremraj, Xueqiu Jian, Alfred Kongnyu NJAMNSHI, Sudha S. Seshadri, Alice B. S. Nono Djotsa, Jayandra Jung Himali et al. · 2025 · bioRxiv (Cold Spring Harbor Laboratory)
  10. Progressive changes in synapses and glial cells in AppNL-G-F mice, a model of Alzheimer’s disease
    Megan Tomlin, Marina Podpolny, Patricia C. Salinas · 2025 · Brain Communications
  11. Additional file 4 of Elevated ganglioside GM2 activator (GM2A) in human brain tissue reduces neurite integrity and spontaneous neuronal activity
    Hsieh, Yi-Chen, Joseph Negri, Amy He, Richard V. Pearse, Liu, Lei, Duong, Duc M., Lori Beth Chibnik, Bennett, David A., Nicholas T. Seyfried, Tracy L. Young‐Pearse · 2022 · Figshare
  12. Additional file 1 of A multiscale brain network model links Alzheimer’s disease-mediated neuronal hyperactivity to large-scale oscillatory slowing
    Anne M van Nifterick, Alida A. Gouw, Ronald E. van Kesteren, Philip Scheltens, Cornelis Jan Stam, Willem de Haan · 2022 · Figshare
  13. Additional file 24 of The hibernation-derived compound SUL-138 shifts the mitochondrial proteome towards fatty acid metabolism and prevents cognitive decline and amyloid plaque formation in an Alzheimer’s disease mouse model
    Christina F. de Veij Mestdagh, Frank Koopmans, Jonathan C. Breiter, Jaap A. Timmerman, Pieter C. Vogelaar, Guido Krenning, Huibert D. Mansvelder, Smit, August B., Henning, Robert H., Ronald E. van Kesteren · 2023 · Figshare
  14. Neural reconnection after exposure in high frequency electromagnetic fields: In vivo study
    Milan Paraš, Dragana Šnjegota, Zoran Nj. Ružić, Maja Šibarević, Jovana Grahovac, Radoslav Gajanin, Smiljana Paraš · 2025 · Kragujevac Journal of Science
  15. Digging Deep into Alzheimer Disease: How Electron Microscopy Helps Elucidating Its Pathogenesis
    Sveva Dallere, Antonio Migheli, Alessandro Vercelli · 2026 · Cellular and Molecular Neurobiology
  16. Using diffusion MRI to relate hippocampal subfield microstructure to delayed verbal memory in cognitively intact individuals at genetic risk for developing Alzheimer's disease
    Jennapher Lingo VanGilder, Andrew Hooyman, Sasha Hakhu, Kurt G. Schilling, Leland Hu, Yuxiang Zhou, Richard J. Caselli, Leslie C. Baxter, Scott C. Beeman · 2026 · Experimental Gerontology
  17. Implication des métabolites de l'APP dans les troubles mnésiques précoces chez la souris TgCRND8, un modèle de la maladie d'Alzheimer
    Valentine Hamm · 2016 · theses.fr (ABES)
  18. NMDA receptor of the blood brain barrier : mechanism of action and interaction with tPA
    Anupriya Mehra · 2017
  19. Mécanisme d’activation neuronale de mTORC1 et de son altération par le peptide amyloïde β
    Dany Khamsing · 2017 · theses.fr (ABES)
  20. Plasticity of hippocampal synaptic transmission and intrinsic excitability in a mouse model of Alzheimer’s disease
    Nan Jiang · 2019 · theses.fr (ABES)
  21. Analyses des dysfonctions neuronales d’un modèle murin de Paraplégie Spastique Héréditaire
    Baptiste Wilmet · 2019 · theses.fr (ABES)
  22. Dynamique intracellulaire des cellules pyramidales de CA3 dans l'hippocampe pendant les états de veille
    Meryl Malézieux · 2018 · theses.fr (ABES)
  23. Implication of 3S-HS and HS3ST2 in synaptic stability under physiological conditions and in Alzheimer's disease-related tauopahty
    Auriane Maïza · 2019 · theses.fr (ABES)
  24. Structural and functional plasticity of the olfactory bulb inhibitory interneurons during diverse sensory experiences
    Soham Saha · 2019 · theses.fr (ABES)
  25. Pathophysiological role of Pyk2 in the nervous system
    Benoit de Pins · 2019 · theses.fr (ABES)
  26. Impact of α-synuclein fibrillar strains and ß-amyloid assemblies on cultured mouse cortical neurons endo-lysosomal logistics
    Qiao-Ling Chou · 2021 · theses.fr (ABES)
  27. Protein Modifications and Quality Control System: Target for Alzheimer’s Disease Therapy
    Abdullah Md. Sheikh, Shozo Yano, Shatera Tabassum, Jubo Bhuiya, Atsushi Nagai · 2026 · International Journal of Molecular Sciences
  28. Transcriptomic signatures of synaptic loss in Alzheimer’s disease
    Lipeng Sun, Xinyuan Yang, Xiaomeng Xu, Lin Kang, Yingting Zheng, Qi Huang, Wei Xu, Yihui Guan, Ye Shen, J S Liu et al. · 2026 · iScience
  29. Ethno-medicinally important plants and their nanotechnological approaches through pharmacological system for managing Alzheimer’s disease: A narrative review
    Himanshu Gogoi, Piyali Dey · 2026 · Pharmacological Research - Natural Products
  30. Exercise and neural circuit stability in early Alzheimer’s disease: evidence across memory, executive, cholinergic, and circadian systems
    Qi Li, Mingchen Gu, Wenhua Li · 2026 · Frontiers in Aging Neuroscience
  31. Effects of metformin and exercise on Alzheimer's model induced by D-galactose in the rats: A behavioral, histological and BDNF gene study
    Tahereh Varmazyar, Nasrin Heidariyeh, Shima Ababzadeh · 2026 · Biochemistry and Biophysics Reports
  32. Alcohol-driven AMPA receptor dysregulation across the lifespan
    Jessica L. Hoffman · 2026 · Physiology & Behavior
  33. Brain transcriptome-wide association study reveals selective long-term potentiation enrichment and negative directional skew of senescence-regulation pathways in Alzheimer's disease
    Ngo Cheung · 2026 · Journal of Alzheimer s Disease Reports
  34. Transcriptomic analysis reveals and validates lipid raft–associated biomarkers and functional networks in Alzheimer’s disease
    Chun‐Hsien Hsu, Amadou Wurry Jallow, Fatima Saleem, Thi Minh Chau Vu, Yung‐Feng Lin · 2026 · IBRO Neuroscience Reports
  35. Silent clues in blood: Proteomic approach for Alzheimer’s disease
    Adriele Rebeca Vieira da Silva, Renata Santos Vieira da Conceição, Carla Mariana da Silva Medeiros, Michely da Silva Sousa, Jemmyson Romário de Jesus, Cícero Alves Lopes Júnior · 2026 · International review of neurobiology
  36. Multidimensional Neuroprotective Effects of Combined Ubisol-Q10 and Ashwagandha (Withania somnifera) in Male and Female 5XFAD Mice
    Keanna Dube, Alex Stoinescu, Julia Sadler, Michelle Truong, Natasha Jaleh Malakoti-Negad, Maira Chaudhry, Rohan Talukdar, Jerome S. Cohen, Siyaram Pandey · 2026 · Nutrients
  37. Human multiscale transcriptomics identifies the NLRP3 inflammasome as a convergent druggable target in Alzheimer’s disease: validation with dimethyl itaconate in 5xFAD mice
    Nayeong Kim, Da Som Jeong, Yongho Lee, Chang-Myung Oh · 2026 · Research Square
  38. BindingDB Entry 50003285: Pyridine bioisosteres of potent GluN2B subunit containing NMDA receptor antagonists with benzo[7]annulene scaffold.
    BindingDB · 2020 · UC San Diego
  39. BindingDB Entry 50007776: Modification of the 4-phenylbutyl side chain of potent 3-benzazepine-based GluN2B receptor antagonists.
    BindingDB · 2021 · UC San Diego
  40. BindingDB Entry 50002929: Hydroxymethyl bioisosteres of phenolic GluN2B-selective NMDA receptor antagonists: Design, synthesis and pharmacological evaluation.
    BindingDB · 2020 · UC San Diego
  41. Optogenetics in neurobiology and neurodegenerative disorders: from neural circuit mechanisms to precision neuromodulation
    V. Singaravel · 2026 · Frontiers in Medical Technology